Myopathy, myasthenia and neuropathy Flashcards
10 patterns of myopathies
- Proximal “Limb‐Girdle” Weakness
- Distal Weakness
- Proximal Arm/Distal Leg (Scapuloperoneal) Weakness
- Distal Arm/Proximal Leg Weakness
- Ptosis with or without Ophthalmoplegia
- Prominent Neck Extensor Weakness
- Bulbar Weakness
- Episodic Weakness/Pain/Rhabdo
- Episodic Weakness Unrelated to Exercise
- Stiffness/Inability to Relax
Sites of myopathic pathology
Muscle Channel
- Muscle Structure
- Membrane proteins
- Sarcomere proteins
- Nuclear proteins
- Muscle Metabolism
6 questions to address myopathy
- Patient’s symptoms and signs?
- Temporal evolution?
- Family history of a myopathic disorder?
- Precipitating factors that trigger episodic weakness or myotonia?
- Associated systemic signs or symptoms?
- Distribution of weakness?
Types of hereditary myopathies
- Muscular dystrophies
- Congenital myopathies
- Myotonias
- Channelopathies
- Metabolic myopathies
- Mitochondrial myopathies
Types of acquired myopathies
- Inflammatory/Immune myopathies
- Myopathies associated with systemic illness
- Endocrine myopathies
- Drug‐induced/toxic myopathies
Distal myopathies
• Late adult onset:
- Welander
- Markesbery/Udd
• Early adult onset:
- Nonaka
- Miyoshi (dysferlinopathy)
- Laing
- Desmin (myofibrillar) myopathy
- Centronuclear myopathy
- Myotonic dystrophy
- Debrancher deficiency
- Miyoshi (dysferlinopathy)
Stiffness/inability to relax
Improves with exercise:
-Myotonia – Na++ or Cl‐ channelopathies
Worsens with exercise:
- Paramyotonia congenita – Na++ channelopathy
With fixed weakness:
- Myotonic dystrophy (DM1)
- Proximal myotonic myopathy (DM2)
- Becker’s disease (AR Cl‐ channelopathy)
Myopathy genetics - X linked diseases
X‐linked - Duchenne MD, Becker MD, Emery‐Dreifuss
Myopathy genetics - Autosomal dominant disease
Autosomal dominant - FSH, LGMD, OPMD, Myotonic dystrophy, PP, PC, Thomsen’s disease, Central core myopathy
Myopathy genetics - Autosomal recessive disease and maternal transmissioon
Autosomal recessive: LGMD, Metabolic myopathies, Becker’s myotonia
Maternal transmission: Mitochondrial myopathies
Clinical features of myotonic dystrophy
CTG triplet repeat genetic mutation with anticipation with each generation
Myotonia
Weakness distal > proximal
Sternomastoid and temporalis wasting
Frontal balding
Diabetes/insulin resistance, hypogonadal, hypopituitary
Cataracts
Intellectual impairment, avoidant personality
Cardiac conduction defects-arrhythmias-yearly ECG
Cardiomyopathy- late
Respiratory and Swallowing difficulties
Differentials for recurrent weakness
Myasthenia, periodic paralysis, CIDP, (porphyria)
Metabolic defects
Differentials for recurrent myalgia
Connective tissue/rheumatoid disease, CIDP, myositis, metabolic defects
Differentials for recurrent rhabdomyolysis
Toxic, viral myositis, dystrophy, metabolic defects
Types of metabolic myopathies
Lipid storage disorder - develops with prolonged sustained exercise and fasting; most common familial form - Carnitine Palmitoyl Transferase; biopsy may be normal or have lipid accumulation
Glycogen storage disorder- occurs with brief intense exercise- McArdle’s myophosphorylase deficiency
Genetics of spinomuscular atrophy
Autosomal recessive gene due to loss of SMN1 on chromosome 5q
Variable penetrance with more severe disease due to loss of “back up” SMN2 genes
4 clinical phenotypes
SMA 1 (2 or 3 copies SMN2) -Severe, neonatal, respiratory failure, death in infancy
SMA 2 (3 copies) - never stand, death after 2yo
SMA 3 (4-8) - stand, death in adulthood
SMA 4 (less marked mutation) - can be adult onset, can ambulate lifelong, normal life expectancy
Genetic therapies for DMD and SMA
Nusinersen, mRNA antisense for interon 7(SMA)
AVXS101 - viral vector replacement of SMA gene
Eteplirsen - mRNA antisense for exon 51, prevent splicing
Clinical features of inflammatory myopathies
- F>M
- Weakness: proximal
- Onset: subacute
- Muscle enzymes: elevated
- EMG: irritable myopathy
- MRI: evidence of inflammation
- Muscle biopsy: inflammation, necrosis, etc…
- Responsive to immunosuppressive therapy
4 Types of immune mediated myopathies
Polymyositis (PM)
Dermatomyositis (DM)
Immune-mediated necrotizing myopathy (IMNM)
Inclusion body myositis (IBM):
Anti-HMG-CoAR induced myopathies
Biopsy: necrotizing in 80%
Nearly 100% proximally weak
75% with myalgias
Maximum CK ~10,000
Requires immunosuppressive therapy to treat
Myopathy associated with statin exposure (~70%)
Progresses despite discontinuing statins
Diagnosis of inclusion body myositis
Degenerative disease of muscle due to cytoplasmic aggregates TDP43
Inclusions 20% of histology; mostly perifascicular inflammation
Anti-NTC51 abs highly specific, titre predicts severity also
Poor response to steroid therapy
Cancers commonly associated with dermatomyositis
Ovarian
Lung
Pancreas
NHL
Stomach
Diagnosis of cancer in DM
anti-p155 antibody has high specific and good NPV for cancer detection in DM
Treatment for myasthenia gravis
IVIg for exacerbation
Pyridostimine (Not effective in MuSK positive patients)
Corticosteroids
Plasmapheresis for crisis
Thymectomy
Other immunosuppressives (marginally effective)